GSK (LON:GSK) Shares Pass Above Two Hundred Day Moving Average - What's Next?

Key Points

• GSK shares surged past their 200-day moving average of GBX 1,432.68, reaching as high as GBX 1,519 ($20.63) during trading.
• Analysts have set varying price targets for GSK, with a consensus average target of GBX 1,637.50, while ratings include one Buy, two Holds, and one Sell.
• Insider trading activity included purchases of 1,930 shares by insiders in the past 90 days, indicating confidence in the company's performance.

GSK plc (LON:GSK - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,432.68 ($19.46) and traded as high as GBX 1,519 ($20.63). GSK shares last traded at GBX 1,517.49 ($20.61), with a volume of 4,955,833 shares trading hands.

Analysts Set New Price Targets

A number of research firms have weighed in on GSK. Berenberg Bank restated a "hold" rating and issued a GBX 1,600 price target on shares of GSK in a research note on Friday, July 18th. JPMorgan Chase & Co. cut their target price on GSK from GBX 1,460 to GBX 1,400 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a GBX 1,450 target price on shares of GSK in a research report on Thursday, July 31st. Finally, Shore Capital reiterated a "buy" rating and set a GBX 2,100 target price on shares of GSK in a research report on Wednesday, August 27th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of GBX 1,637.50.

GSK Price Performance

The stock has a 50-day moving average price of GBX 1,426.91 and a 200 day moving average price of GBX 1,432.68. The company has a debt-to-equity ratio of 114.64, a current ratio of 0.81 and a quick ratio of 0.73. The firm has a market cap of £61.22 billion, a price-to-earnings ratio of 1,837.97, a PEG ratio of 1.24 and a beta of 0.31.

GSK (LON:GSK - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported GBX 75.30 earnings per share (EPS) for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. As a group, equities research analysts forecast that GSK plc will post 175.980975 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Wendy Becker bought 545 shares of GSK stock in a transaction dated Friday, June 20th. The stock was bought at an average price of GBX 1,435 per share, for a total transaction of £7,820.75. Also, insider Jonathan Symonds bought 1,350 shares of GSK stock in a transaction dated Friday, June 20th. The stock was purchased at an average price of GBX 1,435 per share, with a total value of £19,372.50. Insiders purchased a total of 1,930 shares of company stock worth $2,769,931 in the last 90 days. 0.20% of the stock is currently owned by insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.